BiotechTube
Home/Alethio Therapeutics/Professor Beth Psaila
PB

Professor Beth Psaila

Co-Founder

Alethio Therapeutics

Therapeutic Areas

OncologyHematology

Alethio Therapeutics Pipeline

DrugIndicationPhase
AT-01 (ATX-011)Myeloproliferative Neoplasms (MPNs)Pre-clinical
AT-02Mutant CALR-driven Myeloproliferative Neoplasms (MPNs)Pre-clinical

Leadership Team at Alethio Therapeutics

RB
Rohit Batta, MD
Chief Executive Officer
MG
Mike Grey
Chair of the Board
PA
Professor Adam Mead
Co-Founder
View full Alethio Therapeutics profile